nadiia has a phd in molecular health from eth, an mba (focus corporate finance) from hsg, and a msc in molecular biology from uni goettingen / max planck.
her life sciences experience includes working with advanced analytics and molecular tools (convolutional neural networks – CNNs; viral vectors: AAV, lentiviruses; bioprocessing, crispr, omics). she previously worked at partners group, kieger, and began her career in bioprocessing with sartorius in 2009.
nadiia is an investor with over 14 years of combined expertise in life sciences and finance. her career spans the entire spectrum of capital markets: sell-side m&a, private equity, and listed equity investments. she invested in large and small companies, with a focus on sub-sectors including medtech, it/tech, tools, cdmo, cro, and pharma/biotech.
experience with advanced analytics and molecular tools
an education from top universities
deep life sciences and finance expertise
investor
"my passion is what i do. i love investing because it is a way for me to give back to the companies and the broader life science ecosystem."
"my passion is what i do. i love investing because it is a way for me to give back to the companies and the broader life science ecosystem."
investment team
+
dr. nadiia wyttenbach
managing director
investor
investment team
+
dr. nadiia wyttenbach
managing director
+
investor
investor
investor
"my passion is what i do. i love investing because it is a way for me to give back to the companies and the broader life science ecosystem."
"my passion is what i do. i love investing because it is a way for me to give back to the companies and the broader life science ecosystem."
nadiia has a phd in molecular health from eth, an mba (focus corporate finance) from hsg, and a msc in molecular biology from uni goettingen / max planck.
her life sciences experience includes working with advanced analytics and molecular tools (convolutional neural networks – CNNs; viral vectors: AAV, lentiviruses; bioprocessing, crispr, omics). she previously worked at partners group, kieger, and began her career in bioprocessing with sartorius in 2009.
nadiia is an investor with over 14 years of combined expertise in life sciences and finance. her career spans the entire spectrum of capital markets: sell-side m&a, private equity, and listed equity investments. she invested in large and small companies, with a focus on sub-sectors including medtech, it/tech, tools, cdmo, cro, and pharma/biotech.
experience with advanced analytics and molecular tools
an education from top universities
deep life sciences and finance expertise
investment team
+
dr. nadiia wyttenbach
managing director
investor
investment team
+
dr. nadiia wyttenbach
managing director
+
investor
investor
"high-growth companies face unique challenges, and they need knowledgeable and well-connected capital markets. this is why i work."
deep life sciences and finance expertise
nadiia is an investor with over 14 years of combined expertise in life sciences and finance. her career spans the entire spectrum of capital markets: sell-side m&a, private equity, and listed equity investments. she invested in large and small companies, with a focus on sub-sectors including medtech, it/tech, tools, cdmo, cro, and pharma/biotech.
experience with advanced analytics and molecular tools
her life sciences experience includes working with advanced analytics and molecular tools (convolutional neural networks – CNNs; viral vectors: AAV, lentiviruses; bioprocessing, crispr, omics). she previously worked at partners group, kieger, and began her career in bioprocessing with sartorius in 2009.
an education from top universities
nadiia has a phd in molecular health from eth, an mba (focus corporate finance) from hsg, and a msc in molecular biology from uni goettingen / max planck.